Clinical Trials in Ürümqi, Xinjiang Uygur Autonomous Region
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 2
JS207 Combination Therapy in Triple-negative Breast Cancer
Triple-Negative Breast Cancer
Shanghai Junshi Bioscience Co., Ltd.80 enrolled22 locationsNCT07045311
Recruiting
Not Applicable
Helium-free Magnetocardiography Guided Therapy for Stable Coronary Artery Disease - A Randomized Controlled Trial
Stable Coronary Artery Disease CAD
Beijing Anzhen Hospital1,312 enrolled5 locationsNCT07341932
Recruiting
Not Applicable
Safety and Efficacy of Ventricular Irrigation for Ventriculitis
Central Nervous System Infections
RenJi Hospital310 enrolled35 locationsNCT06358209
Recruiting
Phase 2Phase 3
ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (APEX-03)
Hematologic Malignancies
Beijing InnoCare Pharma Tech Co., Ltd.226 enrolled53 locationsNCT06378138
Recruiting
Phase 2
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
ThrombocytopeniaConnective Tissue Diseases
Beijing Hospital296 enrolled23 locationsNCT05998759
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856
Recruiting
Phase 1Phase 2
A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.107 enrolled25 locationsNCT05959694
Recruiting
Real-world Study Optimizing Nucleotide-analogues
Hepatitis B, Chronic
Huashan Hospital20,000 enrolled44 locationsNCT05937178